What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss
Why These Changes Matter Enhanced Heart Health Lower blood pressure and improved lipid profiles significantly reduce the risk of heart attacks, strokes, and other cardiovascular events
A study published Wednesday in the journal Nature finds that part of the reason peoples responses to the drugs vary so widely may be in their DNA
If you experience symptoms of a Jarisch-Herxheimer reaction, let your doctor know
Liu khi u ca Saxenda l 0,6mg tim di da 1 ln/ngy, tng dn liu hng tun cho n khi t liu iu tr l 3mg/ngy
